DermaSensor

FDA Greenlights First AI-Powered Device to Detect All 3 Common Skin Cancers

The US Food and Drug Administration (FDA) has cleared the first AI-powered handheld medical device to assist physicians in detecting common skin cancers. This technology aims to offer a more accurate way of detecting all three common skin cancers, namely basal cell carcinoma, squamous cell carcinoma, and melanoma. FDA Clearance Granted for First AI-Powered Medical …

FDA Greenlights First AI-Powered Device to Detect All 3 Common Skin Cancers Read More »